Preliminary evidence to recommendations framework regarding use of recombinant zoster vaccine in immunocompromised adults and next steps [PDF]
03-ZosterVaccines-Anderson-508 ...
core
A Review of Cutaneous Viral Infections and Their Potential Role in Neurologic Diseases. [PDF]
Duque-Clavijo V, Doan HQ, Tyring SK.
europepmc +1 more source
SUPPLEMENTARY TABLE 1. Search strategy to identify recombinant zoster vaccine (RZV) reports of selected pre-specified outcomes in the Vaccine Adverse Events Reporting System (VAERS) \u2014 United States, October 2017\u2013June 2018 [PDF]
Supplementary table for: Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) \u2014 United States, October 2017\u2013June 2018.20192019-01-29T00:00 ...
core
Heterologous Prime-Boost with ChAdOx1-VZV Establishes Dual-Layer Immunogenicity Conferring Protective Potential Against Herpes Zoster. [PDF]
Zhao J +6 more
europepmc +1 more source
Reply to: Methodological Issues in Taquet et al.'s analysis preclude any conclusions regarding AS01 adjuvant's specific role in dementia prevention. [PDF]
Taquet M, Todd JA, Harrison PJ.
europepmc +1 more source
Transient Increased Risk of Shingles Post-Shingrix Vaccination: Self-Controlled Case-Series Analysis. [PDF]
Shetty AN +5 more
europepmc +1 more source
Varicella-Zoster Virus Infection and Varicella-Zoster Virus Vaccine-Related Ocular Complications. [PDF]
Yu J, Li H, Ji Y, Liao H.
europepmc +1 more source
First case of lupus induced by the Shingrix vaccine: a case report and literature review. [PDF]
Arévalo-Cañas C +2 more
europepmc +1 more source

